Dieses Ergebnis aus ScienceDirect kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

Title:	Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Authors:	Koren, Michael A ^{a, *}; Lin, Leyi ^a; Eckels, Kenneth H ^b; De La Barrera, Rafael ^b; Dussupt, Vincent ^{c, d, h}; Donofrio, Gina ^{c, d, h}; Sondergaard, Erica L ^e; Mills, Kristin T ^e; Robb, Merlin L ^h; Lee, Christine ^e; Adedeji, Oluwaseun ⁱ; Keiser, Paul B ^a; Curley, Justin M ^e; Copeland, Nathanial K ^e; Crowell, Trevor A ^{c, d, h}; Hutter, Jack N ^e; Hamer, Melinda J ^e; Valencia-Ruiz, Anais ^{f, h}; Darden, Janice ^{f, h}; Peel, Sheila ^{f, h}; Amare, Mihret F ^{c, h}; Mebrahtu, Tsedal ^{c, d, h}; Costanzo, Margaret ^{d, h}; Krebs, Shelly J ^{c, d, h}; Gromowski, Gregory D ^a; Jarman, Richard G ^a; Thomas, Stephen J ^a; Michael, Nelson L ^g; Modjarrad, Kayvon ^c
Source:	In The Lancet Infectious Diseases October 2023 23(10):1175-1185
Database:	ScienceDirect